For more than 50 years, various foam sclerosing agents have been used with great enthusiasm by surgeons, phlebologists and angiologists for any kind of varicose veins 1,2 . Numerous publications, especially in the last few years, have stressed the advantages of foam sclerosing agents on the basis of empirical and experimental criteria and have described various individual techniques to prepare foam 3Ð5 . Ultrasound-guided foam sclerotherapy constitutes an attractive therapeutic option for varicose veins.
Sclerosing foam is generally defined as a mixture of gas and liquid sclerosing solution with tension-active properties 6 , but within this definition, foams may dramatically differ from each other. Besides being composed of different specific ingredients, foam can differ in compactness, durability and density. Compactness is related to the size of the air bubbles. Macrofoam contains bubbles larger than 500 µm, and microfoam is composed of bubbles smaller than 250 µm 7 . Since smaller bubbles ensure better contact with the endothelium for most therapeutic purposes, experts generally prefer microfoam. The ideal foam should be durable enough to allow injection before separating into its gas and liquid components, and yet ephemeral enough to break down once it is injected. Density is the fluidÐgas ratio in the foam. These properties are determined by sclerosant concentration, temperature, pH and quantity of sclerosant and gas used. Debate continues over the ideal parameters for producing the most effective foam 8 .
It appears that sclerotherapy has the same results as surgery in the first few years following treatment, but it is inferior to surgery in the long term 9 . Long-terms results with foam sclerotherapy are scanty. Recurrence rates of 20Ð33% are reported in the literature after two years of follow up 5,10 . Foam sclerotherapy holds several advantages over traditional liquid sclerotherapy 11,12 . Once a liquid is injected, it mixes with the blood in the vein and the concentration of the sclerosant is diluted. Foam, on the other hand, displaces the blood allowing direct contact of the sclerosant with the endothelium. The efficacy of a given concentration of sclerosant is effectively increased when used as foam instead of liquid, resulting in a lower concentration of a given sclerosant to treat veins. This increases the safety of sclerotherapy. Greater safety is also achieved with 
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foam for other reasons. A given volume of liquid can be used to produce four or five times its volume in foam, depending on the foaming method. This allows the use of lower total dose of the sclerosant to achieve the desired effect. Moreover, extravasated foam is much better tolerated than extravasated liquid. Probably the most significant advantage of foam is the fact that the air contained within it is echogenic. This dramatically increases visibility and accuracy when performing duplexguided sclerotherapy 8 . Foam sclerotherapy is not without complications. The stress that foam places on the human respiratory system is still unclear, although complication rates are exceedingly low. The VEDICO trial looked at lung scintigraphy in select patients who received foam, but found no perfusion defect even after injections of up to 10 ml of foam 8 . Some propose a limit of 3 ml of foam per session 6 , while others suggest less than 10 ml and others routinely use up to 40 ml without serious sequelae. However, when larger doses are used there are incidents of dry chest, chest discomfort, transient ischaemic attacks and scotomas 13 . In a prospective study of large volume foam sclerotherapy for varicose veins, no deep vein thrombosis was detected in patients experiencing leg pain or swelling after the procedure 13 . But since DVT can be clinically silent, some occurrences may have been missed. In what circumstances is thromboprophylaxis necessary? Again, no convincing studies exist to establish a clear guideline.
Even in the hands of experienced physicians under ideal conditions, necrosis might still occur after sclerotherapy. The consequences can be severe, especially when a high concentration of solution is used. Studies have revealed that a precapillary arteriovenous shunt might allow a direct flow of sclerosant from the venous to the arterial circulation 14 . Therefore, even with expert technique using a conservative sclerosant dose and concentration, cutaneous ulcerations may occur.
Foam sclerotherapy is a new technique with the promise of great efficacy and versatility when used properly 12 . It is a safe, effective, patient-friendly, low-cost outpatient procedure with excellent shortand mid-term results. A comparison of surgery versus sclerotherapy is needed to clarify the issue of the long term outcomes. 
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Erratum
It is regretted that there was an error in the editorial by W G Fegan, entitled ÔVaricose veins: cause and treatmentÕ in the March 2004 issue of Phlebology (Vol 19 No 1). The amended paragraph from page 2 is reproduced below, with the correction appearing in italics.
When this dilatation results in valvular incompetence at the termination of the long saphenous vein... A varicose ulcer occurs due to defective absorption of tissue fluid in the semi-permeable segment of the venous tree, between the capillary and the fully formed vein. This is due to the unfavourable differential between the hydrostatic pressure and the osmotic pressure of the plasma proteins.
